PLSE Annual EBIT
-$43.57 M
+$14.48 M+24.95%
31 December 2023
Summary:
As of January 23, 2025, PLSE annual earnings before interest & taxes is -$43.57 million, with the most recent change of +$14.48 million (+24.95%) on December 31, 2023. During the last 3 years, it has risen by +$6.39 million (+12.79%). PLSE annual EBIT is now -875.25% below its all-time high of -$3.75 million.PLSE EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PLSE Quarterly EBIT
-$13.65 M
-$1.93 M-16.45%
30 September 2024
Summary:
As of January 23, 2025, PLSE quarterly earnings before interest & taxes is -$13.65 million, with the most recent change of -$1.93 million (-16.45%) on September 30, 2024. Over the past year, it has dropped by -$3.04 million (-28.64%). PLSE quarterly EBIT is now -1737.82% below its all-time high of -$743.00 thousand, reached on March 31, 2015.PLSE Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PLSE TTM EBIT
-$48.53 M
-$2.40 M-5.21%
30 September 2024
Summary:
As of January 23, 2025, PLSE TTM earnings before interest & taxes is -$48.53 million, with the most recent change of -$2.40 million (-5.21%) on September 30, 2024. Over the past year, it has dropped by -$3.90 million (-8.74%). PLSE TTM EBIT is now -6431.49% below its all-time high of -$743.00 thousand, reached on March 31, 2015.PLSE TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PLSE EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.9% | -28.6% | -8.7% |
| 3 y3 years | +12.8% | +11.4% | +23.0% |
| 5 y5 years | -14.8% | +7.8% | +19.1% |
PLSE EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +30.9% | -56.1% | +24.2% | -22.0% | +25.0% |
| 5 y | 5-year | at high | +30.9% | -56.1% | +26.3% | -22.0% | +25.0% |
| alltime | all time | -875.3% | +30.9% | -1737.8% | +26.3% | -6431.5% | +25.0% |
Pulse Biosciences EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$13.65 M(+16.5%) | -$48.53 M(+5.2%) |
| June 2024 | - | -$11.73 M(+10.5%) | -$46.13 M(+3.4%) |
| Mar 2024 | - | -$10.62 M(-15.3%) | -$44.63 M(+2.4%) |
| Dec 2023 | -$43.57 M(-24.9%) | -$12.53 M(+11.4%) | -$43.57 M(+9.5%) |
| Sept 2023 | - | -$11.25 M(+10.0%) | -$39.79 M(-14.5%) |
| June 2023 | - | -$10.23 M(+7.0%) | -$46.56 M(-7.5%) |
| Mar 2023 | - | -$9.56 M(+9.3%) | -$50.35 M(-13.3%) |
| Dec 2022 | -$58.06 M(-7.9%) | -$8.74 M(-51.5%) | -$58.06 M(-10.3%) |
| Sept 2022 | - | -$18.02 M(+28.6%) | -$64.72 M(+6.2%) |
| June 2022 | - | -$14.01 M(-18.9%) | -$60.97 M(-1.3%) |
| Mar 2022 | - | -$17.27 M(+12.1%) | -$61.76 M(-2.0%) |
| Dec 2021 | -$63.01 M(+26.1%) | -$15.41 M(+8.0%) | -$63.01 M(+2.7%) |
| Sept 2021 | - | -$14.27 M(-3.6%) | -$61.36 M(+2.3%) |
| June 2021 | - | -$14.81 M(-20.1%) | -$59.99 M(+6.1%) |
| Mar 2021 | - | -$18.52 M(+34.7%) | -$56.54 M(+13.2%) |
| Dec 2020 | -$49.97 M(+4.2%) | -$13.76 M(+6.6%) | -$49.97 M(-0.3%) |
| Sept 2020 | - | -$12.90 M(+13.7%) | -$50.14 M(+1.9%) |
| June 2020 | - | -$11.35 M(-5.0%) | -$49.20 M(-0.6%) |
| Mar 2020 | - | -$11.95 M(-14.2%) | -$49.49 M(+3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$47.95 M(+26.3%) | -$13.93 M(+16.4%) | -$47.95 M(+11.3%) |
| Sept 2019 | - | -$11.96 M(+2.7%) | -$43.08 M(+2.6%) |
| June 2019 | - | -$11.65 M(+11.9%) | -$42.00 M(+5.9%) |
| Mar 2019 | - | -$10.41 M(+14.9%) | -$39.65 M(+4.4%) |
| Dec 2018 | -$37.96 M(+47.1%) | -$9.06 M(-16.7%) | -$37.96 M(+0.6%) |
| Sept 2018 | - | -$10.88 M(+17.0%) | -$37.73 M(+9.8%) |
| June 2018 | - | -$9.30 M(+6.6%) | -$34.38 M(+9.8%) |
| Mar 2018 | - | -$8.72 M(-1.2%) | -$31.30 M(+21.3%) |
| Dec 2017 | -$25.81 M(+169.3%) | -$8.83 M(+17.4%) | -$25.81 M(+30.2%) |
| Sept 2017 | - | -$7.53 M(+21.0%) | -$19.82 M(+31.3%) |
| June 2017 | - | -$6.22 M(+92.2%) | -$15.10 M(+35.6%) |
| Mar 2017 | - | -$3.24 M(+13.9%) | -$11.14 M(+16.2%) |
| Dec 2016 | -$9.59 M(+114.5%) | -$2.84 M(+1.6%) | -$9.59 M(+15.8%) |
| Sept 2016 | - | -$2.80 M(+23.8%) | -$8.28 M(+23.3%) |
| June 2016 | - | -$2.26 M(+34.3%) | -$6.71 M(+24.1%) |
| Mar 2016 | - | -$1.68 M(+9.7%) | -$5.41 M(+21.1%) |
| Dec 2015 | -$4.47 M | -$1.53 M(+24.4%) | -$4.47 M(+52.3%) |
| Sept 2015 | - | -$1.23 M(+29.1%) | -$2.93 M(+72.6%) |
| June 2015 | - | -$956.00 K(+28.7%) | -$1.70 M(+128.7%) |
| Mar 2015 | - | -$743.00 K | -$743.00 K |
FAQ
- What is Pulse Biosciences annual earnings before interest & taxes?
- What is the all time high annual EBIT for Pulse Biosciences?
- What is Pulse Biosciences annual EBIT year-on-year change?
- What is Pulse Biosciences quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Pulse Biosciences?
- What is Pulse Biosciences quarterly EBIT year-on-year change?
- What is Pulse Biosciences TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Pulse Biosciences?
- What is Pulse Biosciences TTM EBIT year-on-year change?
What is Pulse Biosciences annual earnings before interest & taxes?
The current annual EBIT of PLSE is -$43.57 M
What is the all time high annual EBIT for Pulse Biosciences?
Pulse Biosciences all-time high annual earnings before interest & taxes is -$3.75 M
What is Pulse Biosciences annual EBIT year-on-year change?
Over the past year, PLSE annual earnings before interest & taxes has changed by +$14.48 M (+24.95%)
What is Pulse Biosciences quarterly earnings before interest & taxes?
The current quarterly EBIT of PLSE is -$13.65 M
What is the all time high quarterly EBIT for Pulse Biosciences?
Pulse Biosciences all-time high quarterly earnings before interest & taxes is -$743.00 K
What is Pulse Biosciences quarterly EBIT year-on-year change?
Over the past year, PLSE quarterly earnings before interest & taxes has changed by -$3.04 M (-28.64%)
What is Pulse Biosciences TTM earnings before interest & taxes?
The current TTM EBIT of PLSE is -$48.53 M
What is the all time high TTM EBIT for Pulse Biosciences?
Pulse Biosciences all-time high TTM earnings before interest & taxes is -$743.00 K
What is Pulse Biosciences TTM EBIT year-on-year change?
Over the past year, PLSE TTM earnings before interest & taxes has changed by -$3.90 M (-8.74%)